Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 1
1962 3
1963 1
1964 5
1965 1
1966 2
1967 1
1971 1
1983 1
1987 1
1988 1
1991 1
1993 1
1995 3
1996 6
1997 3
1998 7
1999 6
2000 6
2001 3
2002 4
2003 1
2004 3
2005 3
2006 2
2008 5
2009 3
2010 6
2011 7
2012 10
2013 8
2014 14
2015 17
2016 19
2017 20
2018 25
2019 40
2020 46
2021 35
2022 37
2023 34
2024 35

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

362 results

Results by year

Filters applied: . Clear all
Page 1
Tenascin-C as a potential marker for immunohistopathology of doxorubicin-induced cardiomyopathy.
Nishikawa T, Shiba M, Ikeda Y, Ohta-Ogo K, Kondo T, Tabata T, Oka T, Shioyama W, Yamamoto H, Yasui T, Higuchi Y, Ishibashi-Ueda H, Honma K, Izumi C, Higo S, Hatakeyama K, Sakata Y, Fujita M. Nishikawa T, et al. Among authors: izumi c. Eur Heart J Open. 2023 Oct 9;3(5):oead104. doi: 10.1093/ehjopen/oead104. eCollection 2023 Sep. Eur Heart J Open. 2023. PMID: 37908440 Free PMC article.
Diagnosis of cardiac sarcoidosis: histological evidence vs. imaging.
Kurashima S, Kitai T, Xanthopoulos A, Skoularigis J, Triposkiadis F, Izumi C. Kurashima S, et al. Among authors: izumi c. Expert Rev Cardiovasc Ther. 2023 Jul-Dec;21(10):693-702. doi: 10.1080/14779072.2023.2266367. Epub 2023 Oct 26. Expert Rev Cardiovasc Ther. 2023. PMID: 37776232 Review.
Efficacy of azilsartan on left ventricular diastolic dysfunction compared with candesartan: J-TASTE randomized controlled trial.
Ito S, Takahama H, Asakura M, Abe Y, Ajioka M, Anzai T, Arikawa T, Hayashi T, Higashino Y, Hiramitsu S, Iwahashi N, Izumi C, Kimura K, Kinugawa K, Kioka H, Lim YJ, Matsuoka K, Matsuoka S, Motoki H, Nakamura S, Nakayama T, Nomura A, Sasaoka T, Takiuchi S, Toyoda S, Ueda T, Watanabe T, Yamada A, Yamamoto M, Sozu T, Kitakaze M. Ito S, et al. Among authors: izumi c. Sci Rep. 2023 Aug 2;13(1):12517. doi: 10.1038/s41598-023-39779-y. Sci Rep. 2023. PMID: 37532820 Free PMC article. Clinical Trial.
DAPagliflozin for the attenuation of albuminuria in Patients with hEaRt failure and type 2 diabetes (DAPPER study): a multicentre, randomised, open-label, parallel-group, standard treatment-controlled trial.
Yoshihara F, Imazu M, Sakuma I, Hiroi Y, Hara H, Okazaki O, Ishiguro C, Izumi C, Noguchi T, Shiraiwa T, Nishioka N, Fujii K, Iwakura K, Tomonaga O, Kobayashi K, Takihata M, Yumoto K, Takase H, Himi T, Shimizu I, Murakami T, Wagatsuma K, Sato K, Hiramatsu T, Akabame S, Hata S, Asakura M, Kawabata T, Omae K, Ito S, Kitakaze M; DAPPER Investigators. Yoshihara F, et al. Among authors: izumi c. EClinicalMedicine. 2023 Nov 27;66:102334. doi: 10.1016/j.eclinm.2023.102334. eCollection 2023 Dec. EClinicalMedicine. 2023. PMID: 38192595 Free PMC article.
Practical guidance for echocardiography for cancer therapeutics-related cardiac dysfunction.
Onishi T, Fukuda Y, Miyazaki S, Yamada H, Tanaka H, Sakamoto J, Daimon M, Izumi C, Nonaka A, Nakatani S, Akaishi M; Guideline Committee of the Japanese Society of Echocardiography. Onishi T, et al. Among authors: izumi c. J Echocardiogr. 2021 Mar;19(1):1-20. doi: 10.1007/s12574-020-00502-9. Epub 2020 Nov 7. J Echocardiogr. 2021. PMID: 33159650 Free PMC article. Review.
362 results